Classified by application
All Products
Signaling Pathways
- Angiogenesis/Protein Tyrosine Kinase
- Apoptosis Pathway
- Cell Cycle/DNA Damage
- Epigenetics
-
GPCR/G Protein
- Neurotensin Receptor
- Melatonin Receptor
- Urotensin Receptor
- Glucose Transporter
- Motilin Receptor
- TGR5
- Cholecystokinin Receptor
- Somatostatin Receptor
- Adenylate Cyclase
- Oxytocin Receptor
- Bradykinin Receptor
- Guanylate Cyclase
- Melanocortin Receptor
- Imidazoline Receptor
- Neuropeptide Receptor
- PAR
- CRFR
- Sigma Receptor
- S1P Receptor
- GHSR
- PKA
- Adenosine Receptor
- OX Receptor
- Prostaglandin Receptor
- Glucagon Receptor
- NK Receptor
- GnRH Receptor
- Leukotriene Receptor
- Glucocorticoid Receptor
- mAChR
- P2 Receptor
- GPR
- CGRP Receptor
- CXCR
- Histamine Receptor
- CaSR
- Ras/Rho
- Opioid Receptor
- Vasopressin Receptor
- Smoothened/Smo
- mGluR
- Dopamine Receptor
- Cannabinoid Receptor
- Angiotensin Receptor
- Adrenergic Receptor
- SGLT
- Endothelin Receptor
- CCR
- 5 HT Receptor/Serotonin Receptor
- Hormone Pathay
- Ion Channel/Membrane Transporter
- Jak/Stat Pathway
- MAPK Pathway
- Microbiology/Virology
-
Neuro Signaling Pathway
- Monoamine Oxidase
- Imidazoline Receptor
- COMT
- Amyloid β
- NK Receptor
- Beta secretase
- AChE
- SSRI
- CaMK
- P glycoprotein
- Opioid Receptor
- Dopamine Receptor
- mGluR
- Histamine Receptor
- Adrenergic Receptor
- Gamma secretase
- Dopamine Transporter
- 5 HT Receptor/Serotonin Receptor
- P2 Receptor
- nAChR
- CGRP Receptor
- FAAH
- COX
- GABA Receptor
- mAChR
- NFκB
- PI3K/Akt/mTOR
-
Protease/Metabolic Enzyme
- COMT
- 11β HSD
- Carboxypeptidase
- Xanthine Oxidase
- Mitochondrial Metabolism
- ACC
- Pyruvate Kinase
- ALDH
- SCD
- Serine Protease
- CETP
- Neprilysin
- MAGL
- MLR
- FTase
- Carbonic Anhydrase
- Elastase
- E1 E2 E3 Enzyme
- PAI1
- ROR
- NOX
- Glucokinase
- Aldose Reductase
- FAS
- Tyrosinase
- DGAT
- Lipoxygenase
- Nampt
- IDO
- IDH
- MMP
- Cathepsin
- Phosphatase
- Thrombin
- FXR
- RAR/RXR
- HMGCR
- FAAH
- Gamma secretase
- RAAS/ACE
- Caspase
- HIV Protease
- Aminopeptidase
- HSP
- HCV Protease
- Tryptophan Hydroxylase/TPH
- Factor Xa
- DPP
- Procollagen C Proteinase
- Integrase
- Phospholipase
- Phosphodiesterase/PDE
- LXR
- Proteasome
- Cytochrome P450
- TGF beta/Smad
- Wnt/Stem Cell
- Others Pathway
Research Areas
- Metabolic Disease
- Neurological Disease
- Diabetes
- Endocrinology
- Cardiovascular Disease
- Immunology
- Allergy
- Inflammation
- Infection
- Cancer
Nature products
Antibodies
Peptides
Catalysts
Impurities
Intermediate
- Amino acid
- Ammonia Series
- Pyridazine Series
- Azaindazole
- Nucleoside Series
- Quinazoline
- Pyrazole Series
- Quinoline Series
- Pyrimidine Series
- Boric acid
- Pyrrole Series
- Thiophene Series
- Saccharide
- Azaindole
- Indole Series
- Indazole Series
- Piperidine Series
- Heterocyclic Series
- Pyridine Series
- Benzene Series
Raw Materials
BTK
Chemical Structure | Cat. No. | Product Name | CAS No. |
---|
![]() |
BCP44110 | RN983 New | 1423129-83-2 |
RN983 is a selective BTK enzyme inhibitor.
|
![]() |
BCP44097 | BIIB068 New | 1798787-27-5 |
BIIB068 is a potent, selective, reversible and orally active BTK inhibitor.
|
![]() |
BCP44090 | TL-895 New | 1415823-49-2 |
TL-895 is a potent, orally active, ATP-competitive, and highly selective irreversible BTK inhibitor with an IC50 and a Ki of 1.5 nM and 11.9 nM, respectively.
|
![]() |
BCP33289 | Tolebrutinib New | 1971920-73-6 |
Tolebrutinib, also known as SAR442168, is a Bruton tyrosine kinase inhibitor.
|
![]() |
BCP43077 | Rilzabrutinib New | 1575596-29-0 |
Rilzabrutinib, also known as PRN1008, is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK).
|
![]() |
BCP42730 | Pirtobrutinib New | 2101700-15-4 |
Pirtobrutinib is a Bruton's tyrosine kinase (BTK) inhibitor and antineoplastic agent.
|
![]() |
BCP40963 | CNX-500 New | 1202758-21-1 |
CNX-500 is a probe consisting of a covalent Btk inhibitor chemically linked to biotin.
|
![]() |
BCP38296 | Olmutinib dihydrochloride New | 1842366-97-5 |
Olmutinib is an orally available, mutant-selective third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) that is being developed for treatment of advanced and metastatic EGFR mutation-positive non-small cell lung cancer (NSCLC).
|
![]() |
BCP37603 | Orelabrutinib New | 1655504-04-3 |
Orelabrutinib is a potent, orally active, and irreversible Bruton's tyrosine kinase (BTK) inhibitor, being developed by InnoCare Pharma, for the treatment of chronic lymphocytic leukaemia.
|
![]() |
BCP36887 | Remibrutinib New | 1787294-07-8 |
Remibrutinib, also known as LOU064, is a Bruton's tyrosine kinase inhibitor.
|
